IRLAB participates in Redeye Technology & Life Science Day on December 3, 2025

Gothenburg, Sweden, November 27, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the Redeye Technology & Life Science Day 2025 on Wednesday, December 3, 2025, in Stockholm, Sweden.

Nomination committee appointed for IRLAB’s annual general meeting 2026

IRLAB receives acceptance for two abstracts at AD/PD™ 2026: The 20th International Conference on Alzheimer’s and Parkinson’s Diseases